Don't Expect to See a Lot More PCSK9 Inhibitor Rxs
May 2017
You'll hear buzz about using the PCSK9 inhibitors, Repatha (evolocumab) or Praluent (alirocumab), in patients with CV disease....
Exclusive Subscriber Content
- Best in class medication learning
- Concise recommendations
- Hundreds of practical resources
Login to access this content.
Login